Effect of astragaloside on renal function and serum IL-1β and IL-17 in mice with mesangial proliferative glomerulonephritis

Effect of astragaloside on renal function and serum IL-1β and IL-17 in mice with mesangial proliferative glomerulonephritis

Objective To investigate the effects of astragaloside IV(ASIV) on renal function of mice with mesangial proliferative glomerulonephritis (MsPGN) and the regulation of serum IL-1β and IL-17. Methods Thirty-two ICR clean male mice were randomly divided into crotrol group, model group, Tripterygium w...

Full description

Bibliographic Details
Main Author:	LIANG Wen-lin, LI Jun, JIN Guang-ming, YAN Jin-sheng, YAO Yuan
Format:	Article
Language:	zho
Published:	Institute of Basic Medical Sciences and Peking Union Medical College Hospital, Chinese Academy of Medical Sciences / Peking Union Medical College. 2020-12-01
Series:	Jichu yixue yu linchuang
Subjects:	mesangial proliferative glomerulonephritis\|astragaloside iv\|renal function\|inflammatory cytokines
Online Access:	http://journal11.magtechjournal.com/Jwk_jcyxylc/fileup/1001-6325/PDF/a191138.pdf

Similar Items

Primary mesangial proliferative glomerulonephritis complicated with renal tubular acidosis： a case report
by: Chen Zongcun, Cai Xiaoyan, Lai Shuchang, Wang Qiuyi, Fu Maoxiong
Published: (2022-09-01)

The therapeutic effect of Shenhua tablet against mesangial cell proliferation and renal inflammation in mesangial proliferative glomerulonephritis
by: Jiayi He, et al.
Published: (2023-09-01)

Suppressor of Cytokine Signaling-1/STAT1 Regulates Renal Inflammation in Mesangial Proliferative Glomerulonephritis Models
by: Jiuxu Bai, et al.
Published: (2018-08-01)

Turner syndrome complicated with mesangial proliferative nephritis: one case report with a literature review
by: Min Lu, et al.
Published: (2024-01-01)

Mesangial proliferative glomerulonephritis with monoclonal immunoglobulin deposits: why nephrobiopsy is crucial
by: O.I. Chub, et al.
Published: (2022-02-01)

Paeoniflorin Inhibits Mesangial Cell Proliferation and Inflammatory Response in Rats With Mesangial Proliferative Glomerulonephritis Through PI3K/AKT/GSK-3β Pathway
by: Bihao Liu, et al.
Published: (2019-09-01)

Astragaloside IV represses high glucose-induced mesangial cells activation by enhancing autophagy via SIRT1 deacetylation of NF-κB P65 subunit
by: Wang X, et al.
Published: (2018-09-01)

Effect of Huaier On the Proliferation of Mesangial Cells in Anti-Thy-1 Nephritis
by: Jiuxu Bai, et al.
Published: (2017-08-01)

Astragaloside IV improves renal function and fibrosis via inhibition of miR-21-induced podocyte dedifferentiation and mesangial cell activation in diabetic mice
by: Wang X, et al.
Published: (2018-08-01)

Changes in renal function and morphological variations of kidney diseases in rheumatoid arthritis patients
by: Yan Tang, et al.
Published: (2024-04-01)

Comparative Proteomics Analysis of Mouse Habu Nephritis Models with and without Unilateral Nephrectomy
by: Lei Chen, et al.
Published: (2016-10-01)

Astragaloside IV, as a potential anticancer agent
by: Dongqin Xia, et al.
Published: (2023-02-01)

Astragalosidic Acid: A New Water-Soluble Derivative of Astragaloside IV Prepared Using Remarkably Simple TEMPO-Mediated Oxidation
by: Lin-Sen Qing, et al.
Published: (2017-07-01)

Astragaloside IV alleviates lipopolysaccharide‐induced preeclampsia‐like phenotypes via suppressing the inflammatory responses
by: Dilihuma Tuerxun, et al.
Published: (2021-03-01)

Therapeutic Potential of Astragaloside IV Against Adriamycin-Induced Renal Damage in Rats via Ferroptosis
by: Lu-Yun Qin, et al.
Published: (2022-03-01)

Astragaloside IV Ameliorates Myocardial Infarction Induced Apoptosis and Restores Cardiac Function
by: Chuang Sun, et al.
Published: (2021-07-01)

A tale of monoclonal immunoglobulin: Clinicopathological analysis of proliferative glomerulonephritis with monoclonal immunoglobulin deposit
by: Priyanka Maity, et al.
Published: (2021-01-01)

In Silico Prediction of Molecular Targets of Astragaloside IV for Alleviation of COVID-19 Hyperinflammation by Systems Network Pharmacology and Bioinformatic Gene Expression Analysis
by: Chenliang Ge, et al.
Published: (2020-09-01)

Astragaloside IV Blunts Epithelial–Mesenchymal Transition and G2/M Arrest to Alleviate Renal Fibrosis via Regulating ALDH2-Mediated Autophagy
by: Dong Li, et al.
Published: (2023-07-01)

Relapsing and Remitting Proliferative Glomerulonephritis With Monoclonal Immunoglobulin Deposits in Association With Infection and Vaccination: A Case Report
by: Simon Moubarak, et al.
Published: (2023-01-01)

Pharmacological Effects of Astragaloside IV: A Review
by: Yutong Liang, et al.
Published: (2023-08-01)

Effect of astragaloside IV on indoxyl sulfate-induced kidney injury in mice via attenuation of oxidative stress
by: Chunlan Ji, et al.
Published: (2018-09-01)

Astragaloside IV Promotes Adult Neurogenesis in Hippocampal Dentate Gyrus of Mouse through CXCL1/CXCR2 Signaling
by: Fei Huang, et al.
Published: (2018-08-01)

Research progress of astragaloside IV in the treatment of atopic diseases
by: Shencun Yu, et al.
Published: (2022-12-01)

Complete biopsy-proven resolution of deposits in recurrent proliferative glomerulonephritis with monoclonal IgG deposits (PGNMIGD) following rituximab treatment in renal allograft
by: Jon Von Visger, et al.
Published: (2019-02-01)

Astragaloside IV inhibits astrocyte senescence: implication in Parkinson’s disease
by: Mei-Ling Xia, et al.
Published: (2020-04-01)

Immunoglobulin M nephropathy nephropathy in adults and adolescents in India: A single-center study of natural history
by: A M Singhai, et al.
Published: (2011-01-01)

Pathophysiology of mesangial expansion in diabetic nephropathy: mesangial structure, glomerular biomechanics, and biochemical signaling and regulation
by: Haryana Y. Thomas, et al.
Published: (2022-08-01)

Expression of the Alpha8 Integrin Chain Facilitates Phagocytosis by Renal Mesangial Cells
by: Ines Marek, et al.
Published: (2018-03-01)

A rare case of proliferative glomerulonephritis with monoclonal IgG2 kappa deposit: a case report
by: Daisuke Ito, et al.
Published: (2022-12-01)

The potential molecular pathways of Astragaloside-IV in colorectal cancer: A systematic review
by: Tang Ziyang, et al.
Published: (2023-11-01)

Astragaloside IV Improves Metabolic Syndrome and Endothelium Dysfunction in Fructose-Fed Rats
by: Feng Zhao, et al.
Published: (2011-05-01)

Astragaloside IV Exerts Cardioprotection in Animal Models of Viral Myocarditis: A Preclinical Systematic Review and Meta-Analysis
by: Zhuang Zhuang, et al.
Published: (2019-11-01)

Recent pharmacological advances in the treatment of cardiovascular events with Astragaloside IV
by: Zehui Xu, et al.
Published: (2023-12-01)

The Effect of Astragaloside IV on Isoproterenol-Induced Myocardial Infarction in Rats
by: Fatemeh Fathizad, et al.
Published: (2019-06-01)

Astragaloside-IV Alleviates Heat-Induced Inflammation by Inhibiting Endoplasmic Reticulum Stress and Autophagy
by: Zhiwei Dong, et al.
Published: (2017-06-01)

Astragaloside IV attenuates IL-1β-induced intervertebral disc degeneration through inhibition of the NF-κB pathway
by: Yueyang Tian, et al.
Published: (2022-12-01)

Astragaloside IV Inhibits the Up-Regulation of Wnt/β-Catenin Signaling in Rats with Unilateral Ureteral Obstruction
by: Li Wang, et al.
Published: (2014-04-01)

Astragaloside IV promotes angiogenesis by targeting SIRT7/VEGFA signaling pathway to improve brain injury after cerebral infarction in rats
by: Zhijie Ou, et al.
Published: (2023-12-01)

Astragaloside IV Protects Ethanol-Induced Gastric Mucosal Injury by Preventing Mitochondrial Oxidative Stress and the Activation of Mitochondrial Pathway Apoptosis in Rats
by: Shumin Qin, et al.
Published: (2019-08-01)